A Model for Enzymatic Regulation via Post-Translational Modifications in Cellular Signaling

Thesis Abstract

Cellular signaling pathways rely heavily on the precise regulation of enzymatic activity, with post-translational modifications (PTMs) serving as critical modulatory mechanisms that influence enzyme function, localization, and interactions. Despite extensive research on individual PTMs, a comprehensive mechanistic model elucidating how different types of PTMs collectively regulate enzymatic activity within complex signaling networks remains underdeveloped. This study aims to develop an integrative theoretical framework—referred to as the Enzymatic Regulation Model via PTMs (ERM-PTMs)—that delineates the dynamic interactions among phosphorylation, acetylation, ubiquitination, and methylation in modulating enzyme activity within cellular signaling contexts. The specific objectives are (1) to systematically review current empirical findings on PTMs affecting key signaling enzymes; (2) to construct a conceptual model integrating the interactions and crosstalk among multiple PTMs influencing enzymatic functions; (3) to validate the proposed model through simulation and experimental data; and (4) to identify potential therapeutic targets for diseases associated with dysregulated PTMs. To achieve these objectives, a mixed-methods research design was employed, combining comprehensive literature review, computational modeling, and experimental validation. The population of the experimental component comprised human cell lines, specifically HEK293 and HeLa cells, which were used due to their well-characterized signaling pathways and ease of genetic manipulation, with a sample size of 60 cell culture experiments. Data collection involved high-throughput mass spectrometry to quantify PTMs and enzyme activity assays, complemented by bioinformatics analyses utilizing publicly available databases such as PhosphoSitePlus and UniProt. The validity and reliability of the experimental instruments were ensured through calibration protocols and replication of measurements, achieving over 90% consistency. Data analysis incorporated multivariate regression analysis to evaluate the relationships among PTMs and enzyme activities, and network analysis methods to visualize PTM crosstalk within signaling pathways. The normative model specification extended from established theories, notably the Kinase-Phosphatase Balance Model and the PTM Crosstalk Compatibility Theory, adapted to incorporate multiple PTMs and their collective influence. Expected findings include detailed characterization of the crosstalk mechanisms whereby phosphorylation and ubiquitination synergistically enhance enzyme activation, while acetylation and methylation modulate enzyme stability and subcellular localization. The model predicts specific PTM patterns associated with hyperactivation or suppression of signaling enzymes, with potential intervention points identified for disease modulation. These insights aim to fill existing gaps in understanding the interplay among diverse PTMs within signaling networks, offering a holistic perspective that integrates molecular, functional, and computational analyses. The study's contribution to knowledge resides in providing a novel, integrative model that captures the complexity of PTM-based enzyme regulation, which has significant implications for targeted therapeutic developments in cancer, neurodegenerative disorders, and immune dysregulation. The main conclusion affirms that PTMs act as a coordinated regulatory code, and that this model offers a predictive framework for understanding and manipulating enzymatic activity in health and disease. It is recommended that future research extend the model to include additional PTMs such as sumoylation and glycosylation, and explore its applicability in vivo. Overall, this study advances the conceptual understanding of PTM-driven regulation in cellular signaling and paves the way for precision medicine strategies targeting enzymatic modifications.